Literature DB >> 16714563

Identification of a novel antigen of Schistosoma mansoni shared with Plasmodium falciparum and evaluation of different cross-reactive antibody subclasses induced by human schistosomiasis and malaria.

Christine Pierrot1, Shona Wilson, Hélène Lallet, Sophia Lafitte, Frances M Jones, Wassim Daher, Monique Capron, David W Dunne, Jamal Khalife.   

Abstract

Plasmodium falciparum and Schistosoma mansoni are often found in human coinfections, and cross-reactive antibodies to different components of the two parasites have been detected. In this work, we identified a cross-reactive S. mansoni gene product, referred to as SmLRR, that seems to belong to the leucine-rich repeat protein family. Comparative analysis of SmLRR revealed 57% similarity with a putative gene product encoded in the P. falciparum genome. Antibodies to SmLRR were found in experimental infections and in both S. mansoni- and P. falciparum-infected individuals. Correlative analysis of human anti-SmLRR responses in Kenya and Uganda suggested that malaria and schistosomiasis drive the immunoglobulin G3 (IgG3) and IgG4 isotypes, respectively, against SmLRR, suggesting that there is differential regulation of cross-reactive isotypes depending on the infection. In addition, the levels of anti-SmLRR IgG4, but not the levels of IgG3, correlated positively with the intensity of S. mansoni infection.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16714563      PMCID: PMC1479256          DOI: 10.1128/IAI.01724-05

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  34 in total

Review 1.  Human antibody effector function.

Authors:  D R Burton; J M Woof
Journal:  Adv Immunol       Date:  1992       Impact factor: 3.543

Review 2.  Mechanisms of resistance to S. mansoni infection: the rat model.

Authors:  J Khalife; C Cêtre; C Pierrot; M Capron
Journal:  Parasitol Int       Date:  2000-12       Impact factor: 2.230

3.  Detailed clinical and ultrasound examination of children and adolescents in a Schistosoma mansoni endemic area in Kenya: hepatosplenic disease in the absence of portal fibrosis.

Authors:  Birgitte J Vennervald; LeeCarol Kenty; Anthony E Butterworth; Curtis H Kariuki; Hilda Kadzo; Edmund Ireri; Clifford Amaganga; Gachuhi Kimani; Joseph Mwatha; Amos Otedo; Mark Booth; John H Ouma; David W Dunne
Journal:  Trop Med Int Health       Date:  2004-04       Impact factor: 2.622

4.  The age-related resistance of rats to Plasmodium berghei infection is associated with differential cellular and humoral immune responses.

Authors:  Estelle Adam; Christine Pierrot; Sophia Lafitte; Claude Godin; Abdelhadi Saoudi; Monique Capron; Jamal Khalife
Journal:  Int J Parasitol       Date:  2003-09-15       Impact factor: 3.981

5.  An unusual receptor tyrosine kinase of Schistosoma mansoni contains a Venus Flytrap module.

Authors:  Jérôme Vicogne; Jean Philippe Pin; Vinca Lardans; Monique Capron; Christophe Noël; Colette Dissous
Journal:  Mol Biochem Parasitol       Date:  2003-01       Impact factor: 1.759

6.  Associations between anti-Schistosoma mansoni and anti-Plasmodium falciparum antibody responses and hepatosplenomegaly, in Kenyan schoolchildren.

Authors:  Joseph K Mwatha; Frances M Jones; Gamal Mohamed; Cynthia W A Naus; Eleanor M Riley; Anthony E Butterworth; Gachuhi Kimani; Curtis H Kariuki; John H Ouma; Davy Koech; David W Dunne
Journal:  J Infect Dis       Date:  2003-04-02       Impact factor: 5.226

Review 7.  Environmental, genetic and immunological factors in human resistance to Schistosoma mansoni.

Authors:  A J Dessein; P Couissinier; C Demeure; P Rihet; S Kohlstaedt; D Carneiro-Carvalho; M Ouattara; V Goudot-Crozel; H Dessein; A Bourgois
Journal:  Immunol Invest       Date:  1992-08       Impact factor: 3.657

8.  Human IgE, IgG4 and resistance to reinfection with Schistosoma haematobium.

Authors:  P Hagan; U J Blumenthal; D Dunn; A J Simpson; H A Wilkins
Journal:  Nature       Date:  1991-01-17       Impact factor: 49.962

9.  The relationship between age, sex, egg-count and specific antibody responses against Schistosoma mansoni antigens in a Ugandan fishing community.

Authors:  Cynthia W A Naus; Mark Booth; Frances M Jones; Jovanice Kemijumbi; Birgitte J Vennervald; Curtis H Kariuki; John H Ouma; Narcis B Kabatereine; David W Dunne
Journal:  Trop Med Int Health       Date:  2003-06       Impact factor: 2.622

10.  Mechanisms underlying the monocyte-mediated antibody-dependent killing of Plasmodium falciparum asexual blood stages.

Authors:  H Bouharoun-Tayoun; C Oeuvray; F Lunel; P Druilhe
Journal:  J Exp Med       Date:  1995-08-01       Impact factor: 14.307

View more
  20 in total

1.  French Haemovigilance Data on Platelet Transfusion.

Authors:  Béatrice Willaert; Mai-Phuong Vo Mai; Cyril Caldani
Journal:  Transfus Med Hemother       Date:  2008-03-19       Impact factor: 3.747

2.  Malaria.

Authors: 
Journal:  Transfus Med Hemother       Date:  2009       Impact factor: 3.747

3.  Malaria.

Authors:  Johannes Blümel; Reinhard Burger; Christian Drosten; Albrecht Gröner; Lutz Gürtler; Margarethe Heiden; Bernd Jansen; Horst Klamm; Wolf-Dieter Ludwig; Thomas Montag-Lessing; Ruth Offergeld; Georg Pauli; Rainer Seitz; Uwe Schlenkrich; Volkmar Schottstedt; Hannelore Willkommen; Karl-Heinz Wirsing von König
Journal:  Transfus Med Hemother       Date:  2008-03-17       Impact factor: 3.747

4.  Plasmodium falciparum dynein light chain 1 interacts with actin/myosin during blood stage development.

Authors:  Wassim Daher; Christine Pierrot; Hadidjatou Kalamou; Jennifer C Pinder; Gabriele Margos; Daniel Dive; Blandine Franke-Fayard; Chris J Janse; Jamal Khalife
Journal:  J Biol Chem       Date:  2010-04-26       Impact factor: 5.157

5.  Coinfection with Plasmodium falciparum and Schistosoma haematobium: additional evidence of the protective effect of Schistosomiasis on malaria in Senegalese children.

Authors:  Magali Lemaitre; Laurence Watier; Valérie Briand; André Garcia; Jean Yves Le Hesran; Michel Cot
Journal:  Am J Trop Med Hyg       Date:  2013-12-09       Impact factor: 2.345

Review 6.  Current status of vaccines for schistosomiasis.

Authors:  Donald P McManus; Alex Loukas
Journal:  Clin Microbiol Rev       Date:  2008-01       Impact factor: 26.132

7.  Antibody isotype analysis of malaria-nematode co-infection: problems and solutions associated with cross-reactivity.

Authors:  Karen J Fairlie-Clarke; Tracey J Lamb; Jean Langhorne; Andrea L Graham; Judith E Allen
Journal:  BMC Immunol       Date:  2010-02-17       Impact factor: 3.615

8.  Short report: Childhood coinfections with Plasmodium falciparum and Schistosoma mansoni result in lower percentages of activated T cells and T regulatory memory cells than schistosomiasis only.

Authors:  Erick M O Muok; Erick M O Mouk; Pauline N M Mwinzi; Carla L Black; Jennifer M Carter; Zipporah W Ng'ang'a; Michael M Gicheru; W Evan Secor; Diana M S Karanja; Daniel G Colley
Journal:  Am J Trop Med Hyg       Date:  2009-03       Impact factor: 2.345

Review 9.  Human schistosomiasis.

Authors:  Daniel G Colley; Amaya L Bustinduy; W Evan Secor; Charles H King
Journal:  Lancet       Date:  2014-04-01       Impact factor: 79.321

10.  Schistosoma mansoni infection reduces the incidence of murine cerebral malaria.

Authors:  Judith H Waknine-Grinberg; Daniel Gold; Ariel Ohayon; Eliezer Flescher; Alina Heyfets; Michael J Doenhoff; Gabriele Schramm; Helmut Haas; Jacob Golenser
Journal:  Malar J       Date:  2010-01-05       Impact factor: 2.979

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.